Loading...
•
Dec 31, 2024
AdaptHealth Q4 2024 Earnings Report
Announced fourth quarter and full-year 2024 results, providing a 2025 outlook.
Key Takeaways
AdaptHealth reported a slight decrease in net revenue for Q4 2024, but net income increased significantly compared to the previous year. The company is focusing on key initiatives like the One Adapt program and leveraging AI to drive long-term success.
Net revenue decreased slightly by 0.2% to $856.6 million compared to Q4 2023.
Net income attributable to AdaptHealth Corp. was $50.3 million, a significant improvement from a net loss of $254.5 million in Q4 2023.
Adjusted EBITDA decreased by 2.0% to $200.6 million compared to $204.6 million in Q4 2023.
Free cash flow increased to $73.1 million from $66.6 million in Q4 2023.
Forward Guidance
The Company is providing its financial guidance for fiscal year 2025, as follows: Net revenue of $3.22 billion to $3.36 billion; Adjusted EBITDA of $670 million to $710 million; Free cash flow of $180 million to $220 million
Positive Outlook
- Net revenue of $3.22 billion to $3.36 billion
- Adjusted EBITDA of $670 million to $710 million
- Free cash flow of $180 million to $220 million
Historical Earnings Impact
Analyze how earnings announcements historically affect stock price performance
Avg. Return Before/After Earnings
Loading earnings performance data...
Loading earnings reaction data...